To rebuild trust in public health: Better communication, fewer mandates, and small wins
Rebuilding trust in the CDC won’t be quick or easy — especially in a divisive political season — but that doesn’t make it any less important.
Rebuilding trust in the CDC won’t be quick or easy — especially in a divisive political season — but that doesn’t make it any less important.
Zach Klaassen engages in a discussion with Vahan Kassabian about the evolving landscape of nonmetastatic castration-resistant prostate cancer (nmCRPC) management. They delve into how novel…
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
A House proposal includes extension of more flexible rules for telehealth and hospital home-care programs. To pay for it, it seeks new limits on pharmacy…
The beginning of the Change Healthcare cyberattack happened when hackers entered a server that lacked multifactor authentication.
A majority of young adults say they would not live in a state that has banned abortion, according to a new survey released Tuesday. In…
Many women seeking abortions this week at a small clinic in Miami-Dade County were surprised to learn about the state’s new six-week ban.
Shortly after City Council acted Thursday to protect transgender people from discriminatory health care laws, Attorney General Ken Paxton issued a threatening statement, vowing to…
Ashish Kamat and Mark Tyson discuss the currently enrolling PIVOT-006 study. Dr. Tyson discusses cretostimogene grenadenorepvec, a conditionally replicating oncolytic adenovirus designed for cancer cell…
metastatic castration-sensitive prostate cancer (mCSPC), apalutamide treatment effect in TITAN patients with mCSPC, phase III randomised TITAN study, robust benefit with apalutamide plus ADT.